Local Institution

Soweto, Gauteng 2013

0 studies enrolling now · 11 studies all time

What they study most

Chronic Myeloid Leukemia, HIV, HIV Infection, HIV, Pediatric, HIV-1 Infection, Lupus, Myeloid Leukemia, Chronic, Chronic-Phase, Philadelphia-Positive Myeloid Leukemia, Rheumatoid Arthritis, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients — Completed
• Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients — Completed
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes — Completed
• Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
• Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive — Stopped early
• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed